Skip to content
Partnerships
News
Contact
Fore Biotherapeutics
Pipeline
Science
Plixorafenib Program
Publications
Patients
Our Science Explained
Clinical Trials
Forte Trial
Expanded Access
Company
About Us
People
Leadership
Investors
Careers
Governance
Search
Pipeline
Science
Plixorafenib Program
Publications
Patients
Our Science Explained
Clinical Trials
Forte Trial
Expanded Access
Company
About Us
People
Leadership
Investors
Careers
Governance
Partnerships
News
Contact
Company
Investors
Fore is backed by top investors with deep industry knowledge and a successful history of forming some of the world’s leading oncology companies.
Read more
About Us
We are a precision oncology company dedicated to developing innovative treatments that provide better outcomes for patients with the hardest-to-treat...
Read more
Careers
Read more
Governance
At Fore, our work is too important not to hold ourselves to the highest standards
Read more
Leadership
As experts in oncology drug development working with executives who have successfully brought multiple new medicines to patients, we are poised to...
Read more
People
At Fore, we strive to pair the best people with the best science to improve the lives of patients everywhere.
Read more